CCP is the sort of company that I think one should invests in for the long term, so the focus should be on its business performance, plus management guidance. The latter has historically been useful, and it has historically been conservative, with management consistently delivering more than promised.
The next guidance should be published in late January 2016. Below are historical guidance figures to give one an idea of what management guidance to expect, and what to make of the metrics that management proffers:
* NPAT and EPS are underlying NPAT and EPS reported, included a 1-off litigation win of $2m, or 4c per share. Actual win transpired to be 4.6c per share. The update in December was probably because the litigation win became known then.
The December 2012 Update was confirmed in January 2013.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)